Evidence map›Paper›PMID 23405206›Full record

ArticlePloS one2013

Calcium mobilization and protein kinase C activation downstream of protease activated receptor 4 (PAR4) is negatively regulated by PAR3 in mouse platelets.

Amal Arachiche, María de la Fuente, Marvin T Nieman

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. GPCR Heterodimers: Implications for Biased Signaling.Handbook of experimental pharmacology · 2026
    Review
  3. Diversification of PAR signaling through receptor crosstalk.Cellular & molecular biology letters · 2022
    Review
  4. Protease Activated Receptors and Arthritis.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Murine cadherin-6 mediates thrombosis in vivo in a platelet-independent manner.Research and practice in thrombosis and haemostasis · 2021
    Article
  7. Article
  8. Loss ofBlood science (Baltimore, Md.) · 2020
    Article
  9. Article
  10. Targeting PAR1: Now What?Trends in pharmacological sciences · 2017
    Review
  11. Review
  12. Review
  13. Article
  14. Biased signaling of protease-activated receptors.Frontiers in endocrinology · 2014
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amal ArachicheDepartment of Pharmacology, Case Western Reserve University, Cleveland, Ohio, United States of America.
María de la Fuente
Marvin T Nieman
Case Western Reserve University · US

Funding

TUMOR METABOLISM PROGRAMP30CA043703 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI MARK R CHANCE · 1987 to 2026
$142.3M
The role of protease activated receptors on platelets.R01HL098217 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI NIEMAN, MARVIN THOMAS · 2010 to 2024
$4.6M
NCI NIH HHS P30 CA043703NCI NIH HHS P30 CA43703NHLBI NIH HHS R01 HL098217
6 · The paper itself

Abstract

Thrombin activates platelets through protease activated receptors (PARs). Mouse platelets express PAR3 and PAR4. PAR3 does not signal in platelets. However, PAR4 is a relatively poor thrombin substrate and requires PAR3 as a cofactor at low thrombin concentrations. In this study we show that PAR3 also regulates PAR4 signaling. In response to thrombin (30-100 nM) or PAR4 activating peptide (AYPGKF), platelets from PAR3(-/-) mice had increased G(q) signaling compared to wild type mice as demonstrated by a 1.6-fold increase in the maximum intracellular calcium (Ca(2+)) mobilization, an increase in phosphorylation level of protein kinase C (PKC) substrates, and a 2-fold increase of Ca(2+) release from intracellular stores. Moreover, platelets from heterozygous mice (PAR3(+/-)) had an intermediate increase in maximum Ca(2+) mobilization. Treatment of PAR3(-/-) mice platelets with P2Y(12) antagonist (2MeSAMP) did not affect Ca(2+) mobilization from PAR4 in response to thrombin or AYPGKF. The activation of RhoA-GTP downstream G(12/13) signaling in response to thrombin was not significantly different between wild type and PAR3(-/-) mice. Since PAR3 influenced PAR4 signaling independent of agonist, we examined the direct interaction between PAR3 and PAR4 with bioluminescence resonance energy transfer (BRET). PAR3 and PAR4 form constitutive homodimers and heterodimers. In summary, our results demonstrate that in addition to enhancing PAR4 activation at low thrombin concentrations, PAR3 negatively regulates PAR4-mediated maximum Ca(2+) mobilization and PKC activation in mouse platelets by physical interaction.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBioluminescence Resonance Energy Transfer TechniquesBlood PlateletsBlotting, WesternCalciumCell Adhesion MoleculesCell Cycle ProteinsEnzyme ActivationEnzyme-Linked Immunosorbent AssayMiceMice, KnockoutPlatelet AggregationProtein Kinase CProtein MultimerizationReceptors, Purinergic P2Y12Adaptor Proteins, Signal TransducingCalciumCell Adhesion MoleculesCell Cycle ProteinsP2ry12 protein, mousePard3 protein, mouseprotease-activated receptor 4Protein Kinase CReceptors, Purinergic P2Y12Receptors, ThrombinrhoA GTP-Binding Protein

Identifiers

PMID23405206
PMCPMC3566007
OpenAlexW1981763570

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.